Back

Percutaneous edge-to-edge repair for systemic tricuspid valve regurgitation in patients with congenital heart disease: the first descriptive cohort

26 August 2022 (14:15 - 15:00)
Organised by:
Congress Presentation Part of: Surgery and intervention in congenital heart disease: moving forward Intervention ESC Professional Premium Access ESC Congress 2022

About the speaker

Photo
Doctor Magalie Ladouceur

University hospitals of Geneva, Geneva (Switzerland)

6 More presentations in this session

Presentation thumbnail
Predictors of long term tricuspid regurgitation after pulmonary valve replacement: a single center study on the cohort of significant preoperative tricuspid regurgitation.
Miss B. Carbonell Prat (Barcelona, ES)
Abstract Slides
Presentation thumbnail
Is bilateral lung transplantation in pulmonary artery hypertension related to congenital heart disease a real therapeutic option? Experience of a national referral centre
Doctor R. Luna (Barcelona, ES)
Abstract Slides
Presentation thumbnail
Outcome of device atrial septal defect closure in different age groups: a nationwide cohort study
Doctor V. Muroke (Montreal, CA)
Abstract Slides
Presentation thumbnail
Single predictor of residual right-to-left shunt to optimally select patients for suture-mediated percutaneous patent fossa ovalis closure
Doctor C. Gaspardone (Milan, IT)
Abstract Slides
Presentation thumbnail
Conservative vs surgical management in ebstein's anomaly: long-term follow-up in a real-life cohort
Doctor C. Merino Argos (Madrid, ES)
Abstract Slides

Access the full session

Session thumbnail
Surgery and intervention in congenital heart disease: moving forward

The Event

Event poster

ESC Congress 2022

26 August 2022 14:15 CET

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources